Market by Animal Type, Disease Type, Product Type, and Country Outlook | Forecast 2022-2028
As per a research report by
Triton, the veterinary vaccines market in Latin America is likely to grow with
a CAGR of 7.89% over the forecasting
duration from 2022 to 2028.
Report scope can be customized per your requirements. Request For Customization
The countries analyzed in this region include:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
The region has some largely untapped markets, which presents a lucrative
opportunity for veterinary vaccine manufacturers to enter and expand business
here. A rising trend of owning & adopting companion animals has been
observed across the region, especially in the last few years. This opens up
growth avenues for the manufacturers of companion animal vaccines.
Brazil accounts for the largest share in the regional market, and its
market growth is boosted by the surging population of companion animals. There
are approximately 52.2 million pet dogs in the country. As per industry
estimates, Brazilians have close to 36 million puppies and small dogs in their
homes, which is the highest figure among other countries across the globe. The
rising concerns among owners about their pets’ health have fueled the demand
for veterinary vaccines.
In Mexico, the growing population of companion animals like cats and
dogs is driving the market’s progress. There are nearly 6.59 million pet cats
and 17 million pet dogs in the country. Cats are vaccinated against Viral
Rhinotracheitis, Feline Panleukopenia (Distemper), Leukemia, and Calicivirus;
whereas, dogs are vaccinated against Hepatitis, Distemper, Parvovirus,
Leptospirosis, and Parainfluenza.
Subunit vaccines do not contain the live components of the pathogen and
contain only its antigenic parts. These parts are essential to elicit a
protective immune response. This accuracy comes at a cost, as the antigenic
properties of several potential subunits of the pathogen require to be examined
in depth in order to assess which particular combinations will generate an
effective immune response within the correct pathway. The studied report assesses the market’s growth based on product type,
disease type, and animal type. Here, the product type segment includes
subunit vaccines, attenuated vaccines, toxoid vaccines, inactivated vaccines,
DNA vaccines, recombinant vaccines, and conjugate vaccines.
Leading companies considered in the veterinary
vaccines market include Vaxxinova GmbH, Zoetis Inc, Merck Animal Health, Ceva
Sante Animale, Elanco Animal Health Inc, and Virbac SA.
Zoetis Inc is a company dealing in the area of animal healthcare. It is
engaged in developing, manufacturing, and commercializing vaccines, medicines,
and diagnostic products. It serves end-users such as livestock producers,
veterinarians, and people who raise & care for farm & companion
animals. Some of the company’s veterinary vaccines are FELOCELL® 3, Vanguard® DAPP-L4,
and Bovi-Shield Gold FP® 5 L5. Zoetis was founded in 1950 as a business unit of
Pfizer Inc. It was incorporated recently in July 2021. The company has a
notable presence in Brazil.
Key deliverables of the
report:
●
Market CAGR during the forecasting years 2022-2028
●
Detailed data highlighting key insights, industry components, and
market strategies
● Comprehensive information and estimation of the veterinary
vaccines market revenue growth in Latin America and its influence on the parent
market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape, vendor
scorecard, and Porter’s Five Forces
● A wide-ranging study of factors that will challenge the LA
veterinary vaccines market’s growth during the upcoming years
Want to get specific insights? Our team of analysts can customize this
report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA VETERINARY VACCINES MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE VETERINARY VACCINES MARKET
2.2. KEY
INSIGHTS
2.2.1. INCREASING
INNOVATION BY MARKET PARTICIPANTS
2.2.2. ADVANCEMENTS
IN VACCINE AND DIAGNOSTIC TECHNOLOGY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VALUE
CHAIN ANALYSIS
2.6. KEY
BUYING CRITERIA
2.7. REGULATORY
FRAMEWORK
2.8. VENDOR
SCORECARD
2.9. KEY
MARKET STRATEGIES
2.9.1. MERGERS
& ACQUISITIONS
2.9.2. CONTRACTS
& AGREEMENTS
2.9.3. PRODUCT
LAUNCHES
2.9.4. EXPANSIONS
& DIVESTITURES
2.10. MARKET
DRIVERS
2.10.1. HIGH
VACCINE DEMAND DUE TO INCREASING ANIMAL POPULATION AND DISEASES
2.10.2. GOVERNMENT-ORGANIZED
VACCINATION DRIVES
2.10.3. ADVANCED
VACCINE RESEARCH AND DEVELOPMENT
2.11. MARKET
CHALLENGES
2.11.1. LACK
OF AWARENESS AND SCARCITY OF SKILLED VETERINARIANS
2.11.2. STRINGENT
RULES AND REGULATIONS PERTAINING TO VACCINE USE
2.12. MARKET
OPPORTUNITIES
2.12.1. RISING
DEMAND FOR COMPANION ANIMALS
3. LATIN
AMERICA VETERINARY VACCINES MARKET OUTLOOK – BY ANIMAL TYPE
3.1. LIVESTOCK
ANIMAL
3.1.1. CATTLE
3.1.2. PIGS
3.1.3. POULTRY
3.1.4. SHEEP
3.1.5. OTHER
LIVESTOCK ANIMALS
3.2. COMPANION
ANIMAL
3.2.1. CANINE
3.2.2. FELINE
3.2.3. EQUINE
3.3. AQUACULTURE
4. LATIN
AMERICA VETERINARY VACCINES MARKET OUTLOOK – BY DISEASE TYPE
4.1. CANINE
DISEASE
4.2. PORCINE
DISEASE
4.3. BOVINE
DISEASE
4.4. POULTRY
DISEASE
4.5. AQUACULTURE
DISEASE
4.6. OTHER
DISEASE TYPE
5. LATIN
AMERICA VETERINARY VACCINES MARKET OUTLOOK – BY PRODUCT TYPE
5.1. ATTENUATED
VACCINES
5.2. INACTIVATED
VACCINES
5.3. TOXOID
VACCINES
5.4. CONJUGATE
VACCINES
5.5. DNA
VACCINES
5.6. RECOMBINANT
VACCINES
5.7. SUBUNIT
VACCINES
6. LATIN
AMERICA VETERINARY VACCINES MARKET – COUNTRY OUTLOOK
6.1. BRAZIL
6.2. MEXICO
6.3. ARGENTINA
6.4. REST
OF LATIN AMERICA
7. COMPETITIVE
LANDSCAPE
7.1. BOEHRINGER
INGELHEIM INTERNATIONAL GMBH
7.2. BRILLIANT
BIO PHARMA
7.3. CEVA
SANTE ANIMALE
7.4. ELANCO
ANIMAL HEALTH INC
7.5. HESTER
BIOSCIENCES LTD
7.6. HIPRA
7.7. INDIAN
IMMUNOLOGICALS LIMITED
7.8. MERCK
ANIMAL HEALTH
7.9. PHIBRO
ANIMAL HEALTH
7.10. VAXXINOVA
GMBH
7.11. VIRBAC
SA
7.12. ZOETIS
INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: LATIN AMERICA
VETERINARY VACCINES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: VENDOR SCORECARD
TABLE 4: LATIN AMERICA
VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)
TABLE 5: LATIN AMERICA
VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 6: LATIN AMERICA
VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 7: LATIN AMERICA
VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 8: LATIN AMERICA
VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: LATIN AMERICA
VETERINARY VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE
1: MARKET ATTRACTIVENESS INDEX
FIGURE
2: VALUE CHAIN ANALYSIS
FIGURE
3: KEY BUYING CRITERIA
FIGURE
4: LATIN AMERICA VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2021 & 2028
(IN %)
FIGURE
5: LATIN AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028
(IN $ MILLION)
FIGURE
6: LATIN AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2021 &
2028 (IN %)
FIGURE
7: LATIN AMERICA VETERINARY VACCINES MARKET, BY CATTLE, 2022-2028 (IN $
MILLION)
FIGURE
8: LATIN AMERICA VETERINARY VACCINES MARKET, BY PIGS, 2022-2028 (IN $ MILLION)
FIGURE
9: LATIN AMERICA VETERINARY VACCINES MARKET, BY POULTRY, 2022-2028 (IN $
MILLION)
FIGURE
10: LATIN AMERICA VETERINARY VACCINES MARKET, BY SHEEP, 2022-2028 (IN $
MILLION)
FIGURE
11: LATIN AMERICA VETERINARY VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS,
2022-2028 (IN $ MILLION)
FIGURE
12: LATIN AMERICA VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028
(IN $ MILLION)
FIGURE
13: LATIN AMERICA VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2021 &
2028 (IN %)
FIGURE
14: LATIN AMERICA VETERINARY VACCINES MARKET, BY CANINE, 2022-2028 (IN $
MILLION)
FIGURE
15: LATIN AMERICA VETERINARY VACCINES MARKET, BY FELINE, 2022-2028 (IN $
MILLION)
FIGURE
16: LATIN AMERICA VETERINARY VACCINES MARKET, BY EQUINE, 2022-2028 (IN $
MILLION)
FIGURE
17: LATIN AMERICA VETERINARY VACCINES MARKET, BY AQUACULTURE, 2022-2028 (IN $
MILLION)
FIGURE
18: LATIN AMERICA VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2021 & 2028
(IN %)
FIGURE
19: LATIN AMERICA VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2022-2028 (IN
$ MILLION)
FIGURE
20: LATIN AMERICA VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2022-2028 (IN
$ MILLION)
FIGURE
21: LATIN AMERICA VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2022-2028 (IN
$ MILLION)
FIGURE
22: LATIN AMERICA VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2022-2028 (IN
$ MILLION)
FIGURE
23: LATIN AMERICA VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2028
(IN $ MILLION)
FIGURE
24: LATIN AMERICA VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2022-2028
(IN $ MILLION)
FIGURE
25: LATIN AMERICA VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2021 & 2028
(IN %)
FIGURE
26: LATIN AMERICA VETERINARY VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2028
(IN $ MILLION)
FIGURE
27: LATIN AMERICA VETERINARY VACCINES MARKET, BY INACTIVATED VACCINES,
2022-2028 (IN $ MILLION)
FIGURE
28: LATIN AMERICA VETERINARY VACCINES MARKET, BY TOXOID VACCINES, 2022-2028 (IN
$ MILLION)
FIGURE
29: LATIN AMERICA VETERINARY VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2028
(IN $ MILLION)
FIGURE
30: LATIN AMERICA VETERINARY VACCINES MARKET, BY DNA VACCINES, 2022-2028 (IN $
MILLION)
FIGURE
31: LATIN AMERICA VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINES,
2022-2028 (IN $ MILLION)
FIGURE
32: LATIN AMERICA VETERINARY VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2028
(IN $ MILLION)
FIGURE
33: LATIN AMERICA VETERINARY VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2028
(IN %)
FIGURE
34: BRAZIL VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE
35: MEXICO VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE
36: ARGENTINA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE
37: REST OF LATIN AMERICA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)